1-4 of 4
Rolando Vallansot
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Thrombogenesis Mechanisms of High Doses of Ponatinib in Patients with Chronic Myeloid Leukemia (CML) Compared to Tyrosine Kinase Inhibitors

Sonia Aguila, Ernesto J Cuenca, Maria Jose Lys, Carmen Garcia-Hernandez, Maria Jose Fernández, Maria Noya, Valentín García Gutiérrez, Luis Palomera, Alicia Senín, Raul Perez Lopez, Manuel Pérez-Encinas, Anna Angona, Jose M Puerta, Rolando Vallansot, Venancio Conesa, Juan Carlos Hernandez Boluda, Ana Rosell, Montse Cortes, Guillermo Ortí, Blanca Xicoy, Gonzalo Carreño, Elvira Mora Castera, Pilar Giraldo, Maria Luisa Lozano, Luis Felipe Casado, Francisca Ferrer Marin, on Behalf Of Gelmc
Journal: Blood
Blood (2022) 140 (Supplement 1): 6730–6732.
https://doi.org/10.1182/blood-2022-163070
Published: 2022
Journal Articles

Coexisting Myeloproliferative and Lymphoproliferative Neoplasms: A European Multicenter Retrospective Study

Dolly Viviana Viviana Fiallo Suarez, Ruth Stuckey, Cristina Bilbao, Maria Tapia Torres, Maria Angelina Lemes Castellano, Fernando Fernández-Fuertes, Leonor Pérez-Ortiz, Oscar Borsani, Elisa Rumi, Jean-Christophe Ianotto, Francisca Ferrer Marin, Mercedes Gasior Kabat, Beatriz Cuevas, Krzysztof Lewandowski, Alberto Alvarez-Larran, Marta Anna Sobas, Marco Santoro, María Ángeles Foncillas, Joanna Drozd-Sokolowska, Zuzanna Kandula, Juan Carlos Hernandez Boluda, Anna Angona, Gonzalo Carreño, María Alicia Senin, Maria Isabel Mata Vazquez, Maria Laura Fox, Rafael Del Orbe, Patricia Velez Tenza, Rolando Vallansot, María Teresa Gómez-Casares
Journal: Blood
Blood (2022) 140 (Supplement 1): 12245–12247.
https://doi.org/10.1182/blood-2022-168900
Published: 2022
Journal Articles

Feasibility of Treatment Discontinuation in Chronic Myeloid Leukemia in Clinical Practice in Spain: Results from a Nationwide Series of 236 Patients

Juan Carlos Hernandez Boluda, MD PhD, Arturo Pereira, MD PhD, Irene Pastor-Galán, MDcal Doctor, Alberto Alvarez-Larrán, MD PhD, Alisa Savchuk, Jose Manuel Puerta, Jose M. Sanchez, Rosa Collado, Álvaro Díaz, Anna Angona, MD PhD, Miguel Sagüés, Valentín García Gutiérrez, PhD, Concepcion Boque, MD PhD, Ignacio Gómez-Centurión, MD, Rolando Vallansot, MD, Luis Palomera, MD PhD, Arantxa Mendizábal, Luis Felipe Casado, MD, Manuel Pérez-Encinas, Raul Perez Lopez, Francisca Ferrer Marin, MD PhD, Fermin Sanchez-Guijo, MD PhD, Carmen Garcia-Hernandez, MD, Natalia de las Heras, Jose Luiz Lopez Lorenzo, MD, Francisco Cervantes, MD PhD, Juan Luis Steegmann, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 47.
https://doi.org/10.1182/blood-2018-99-109976
Published: 2018
Journal Articles

A Conservative Tailoring of Ponatinib Dose in Chronic Myeloid Leukemia Patients Can Diminish Adverse Events While Maintaining Efficacy

Valentín García Gutiérrez, PhD, Andrés Novo, MD, Antonio Jimenez-Velasco, Luis Felipe Casado Montero, MD, Fermin Sanchez-Guijo, MD PhD, Raul Perez Lopez, Santiago Osorio-Prendes, Sunil Lakhwani Lakhwani, Angel Ramirez Payer, Guillermo Orti, Maria Teresa Gomez-Casares, Juan Manuel Alonso, Manuel Pérez-Encinas, Rolando Vallansot, Ernesto Pérez Persona, Maria Angeles Portero Frias, María José Ramírez Sánchez, Maria Alicia Senin, Gonzalo Caballero, Soledad Noya, Concepcion Boque, Maribel Mata, Mario Romo, Juan Luis Steegmann, MD PhD, Juan Carlos Hernandez-Boluda, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1624.
https://doi.org/10.1182/blood.V130.Suppl_1.1624.1624
Published: 2017